|
[1]CONTI F, BUONFIGLIOLI F, SCUTERI A, et al.Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals[J].J Hepatol, 2016, 65 (4) :727-733.
|
|
[2]YU YQ, ZHOU Q, FENG DY.Meta analysis on Fuzhenghuayu capsule combined with nucleoside antiviral drug for chronic hepatitis B[J].J Reg Anat Oper Surg, 2012, 21 (1) :24-28. (in Chinese) 余燕青, 周权, 冯德云.扶正化瘀胶囊联合核苷类抗病毒药物治疗慢性乙型肝炎的meta分析[J].局解手术学杂志, 2012, 21 (1) :24-28.
|
|
[3]ZHANG RF, BI DM, YOU ZL, et al.Efficiency of Fuzheng Huayu Capsule combined with tenofovir in treatment of hepatitis B liver fibrosis[J].J Third Milit Med Univ, 2016, 38 (21) :2363-2367. (in Chinese) 张瑞凤, 毕东敏, 游忠岚, 等.扶正化瘀胶囊联合替诺福韦治疗乙肝肝纤维化的疗效观察[J].第三军医大学学报, 2016, 38 (21) :2363-2367.
|
|
[4]GU C, SONG MY, SUN WJ, et al.Advances in basic and clinical research on liver cirrhosis in 2016[J].Chin J Hepatol, 2017, 25 (1) :5-8. (in Chinese) 古川, 宋美怡, 孙文静, 等.2016年肝硬化领域基础与临床研究进展[J].中华肝脏病杂志, 2017, 25 (1) :5-8.
|
|
[5]XIAO DH, GU J, CAI H, et al.A randomized placebo-controlled multicentre study of Fuzhenghuayu capsule for prevention of oesophageal variceal bleeding in patients with liver cirrhosis[J].Chin JHepatol, 2014, 22 (8) :594-599. (in Chinese) 肖定洪, 顾杰, 蔡虹, 等.扶正化瘀胶囊预防肝硬化患者食管静脉曲张破裂出血的随机对照多中心临床研究[J].中华肝脏病杂志, 2014, 22 (8) :594-599.
|
|
[6]HU K, ZHAO K, TAN QY.Clinical experience in Danning tablets promoting recovery of gallbladder function after laparoscopic gallbladder-preserving cholecystolithotomy in patients with gallstones[J].Clin J Curr Adv Gen Surg, 2015, 18 (6) :491-493. (in Chinese) 胡魁, 赵凯, 谭群亚.胆宁片促进胆囊结石患者腹腔镜保胆取石术后胆囊功能恢复的临床体会[J].中国现代普通外科进展, 2015, 18 (6) :491-493.
|
DownLoad: